Pioneer Surgical Technology,
Inc., a leader in innovative medical devices, announced today the
successful human implantation of its new biologic inter-body spacer. The
nanOss- Cervical cage is machined from mechanically robust
nano-crystalline hydroxyapatite (HA) and is designed to function as bone.
The surgeries were performed at hospitals in Beijing and Suzhou, China, on
patients indicated for standard cervical fusion surgery using the
nanOss-Cervical implant, bone graft material, and anterior cervical
plate.
Dr. Hansen Yuan, Professor of Orthopaedic and Neurological Surgery,
State University of New York Upstate Medical University, Syracuse, NY
performed the surgeries with Chinese surgeons and says, "The
nanOss-Cervical cage was handled and implanted similarly to PEEK
(poly-ether-ether-ketone) cages, and was used in conjunction with routine
rigid fixation. The benefit of nanOss technology to the patient is it is a
safe, natural substance and is biocompatible."
Pioneer's nanOss-Cervical cage is intended to facilitate spinal fusion
procedures, by simultaneously maintaining decompression and serving as a
graft containment device in conjunction with traditional rigid fixation.
Pioneer's CEO and Chairman of the Board, Dr. Matthew N. Songer says,
"The hydroxyapatite nanOss-Cervical design is the frontier of the new
generation of biologic implants that will replace the foreign materials
that are currently used to reconstruct the spine."
In less than a year from acquiring the nanOss technology, Pioneer's
development teams have created the nanOss-Cervical cage for fusion
procedures. Strength properties of materials made of nanOss technology are
twice as strong as PEEK cages yet, being biologic, behave as if it were
bone.
Pioneer Surgical Technology, Inc. is a dynamic medical device firm
founded in 1992. Pioneer's focus on innovation has resulted in over 100
U.S. and Foreign patents with numerous patents pending." The company's
comprehensive portfolio of CE or investigational motion preservation
devices, vertebral spacers, cervical plating systems, and MIS and Mini-Open
Rod systems include notable trade names such as NuBac, BacJac,
Contact, IJAK, Clarity, SlimFuse, and Quantum. Pioneer
entered the orthobiologics market with two acquisitions in 2007.
Encelle, Inc., developed E-Matrix for tissue regeneration.
Angstrom Medica, Inc. is the first company to obtain FDA approval for a
nanotechnology device -- nanOss -- hydroxyapatite bone void filler.
Pioneer's Orthopaedic, Spine, and Biologic divisions produce state of the
art, cost-effective solutions for surgical procedures that have proven
difficult or problematic for both surgeons and patients. Pioneer employs
more than 260 people worldwide.
http://www.pioneersurgical.com/
